Polycystin signaling is required for directed endothelial cell migration and lymphatic development.
暂无分享,去创建一个
Marc K Halushka | M. Halushka | G. Germino | F. Qian | T. Watnick | D. Huso | Patricia Outeda | Steven A Fisher | David L Huso | S. Fisher | Gregory G Germino | Patricia Outeda | Hyunho Kim | Feng Qian | Terry Watnick | Hyunho Kim
[1] K. Brindle,et al. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. S. St George-Hyslop,et al. Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. , 1999, Journal of the American Society of Nephrology : JASN.
[3] R. Parton,et al. Pkd1 regulates lymphatic vascular morphogenesis during development. , 2014, Cell reports.
[4] Laure Gambardella,et al. A Computational Tool for Quantitative Analysis of Vascular Networks , 2011, PloS one.
[5] G. Germino,et al. PKD1 interacts with PKD2 through a probable coiled-coil domain , 1997, Nature Genetics.
[6] K. Caron,et al. Adrenomedullin signaling is necessary for murine lymphatic vascular development. , 2008, The Journal of clinical investigation.
[7] J. Partanen,et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins , 2004, Nature Immunology.
[8] M. Tsai,et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. , 2007, Genes & development.
[9] B. Spencer‐Dene,et al. Regulation of lymphatic-blood vessel separation by endothelial Rac1 , 2009, Development.
[10] Lin Geng,et al. Cardiac defects and renal failure in mice with targeted mutations in Pkd2 , 2000, Nature Genetics.
[11] A. Hall,et al. Integrin-Mediated Activation of Cdc42 Controls Cell Polarity in Migrating Astrocytes through PKCζ , 2001, Cell.
[12] K. Klinger,et al. Polycystin 1 is required for the structural integrity of blood vessels. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Hammer,et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.
[14] J. García-Verdugo,et al. Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos. , 2012, Blood.
[15] A. Hall,et al. Cell polarity: Par6, aPKC and cytoskeletal crosstalk. , 2003, Current opinion in cell biology.
[16] G. Oliver,et al. Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.
[17] G. Secker,et al. In Vitro Assays Using Primary Embryonic Mouse Lymphatic Endothelial Cells Uncover Key Roles for FGFR1 Signalling in Lymphangiogenesis , 2012, PloS one.
[18] M. Arnaout,et al. The vasculopathy of autosomal dominant polycystic kidney disease: insights from animal models. , 2000, Kidney international.
[19] L. Luo,et al. A global double‐fluorescent Cre reporter mouse , 2007, Genesis.
[20] K. Alitalo,et al. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy , 2013, The EMBO journal.
[21] Ann M. Johnson,et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. , 1992, The New England journal of medicine.
[22] G. Germino,et al. Pkd1 and Pkd2 Are Required for Normal Placental Development , 2010, PloS one.
[23] A. Boletta,et al. Polycystin-1 Binds Par3/aPKC and Controls Convergent Extension During Renal Tubular Morphogenesis , 2013, Nature Communications.
[24] C. Edgell,et al. Permanent cell line expressing human factor VIII-related antigen established by hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[25] V. Torres,et al. Polycystic kidney disease. , 2009, Annual review of medicine.
[26] G. Germino,et al. Molecular advances in autosomal dominant polycystic kidney disease. , 2010, Advances in chronic kidney disease.
[27] G. Germino,et al. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. , 2004, Journal of the American Society of Nephrology : JASN.
[28] G. Borisy,et al. Cell Migration: Integrating Signals from Front to Back , 2003, Science.
[29] D. Jackson,et al. LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.
[30] Y. Pirson. Extrarenal manifestations of autosomal dominant polycystic kidney disease. , 2010, Advances in chronic kidney disease.
[31] K. Klinger,et al. Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease. , 1998, Molecular cell.
[32] G. Germino,et al. The Molecular Basis of Focal Cyst Formation in Human Autosomal Dominant Polycystic Kidney Disease Type I , 1996, Cell.